Last updated: 11/07/2018 10:19:03

Influenza burden assessment in the United Kingdom, 1996-2008

GSK study ID
116273
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Burden of Influenza in the United Kingdom, 1996-2008
Trial description: The study will assess the burden of influenza by age, risk status, vaccination status and influenza subtype, in order to create a complete profile of the burden of influenza-related morbidity and mortality in United Kingdom from 1996 to 2008.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Incidence of medically attended health outcomes (~20 relevant mild and severe) related to influenza

Timeframe: From 1996 to 2008 (up to 13 years)

Relative impact of influenza on high versus low risk populations

Timeframe: From 1996 to 2008 (up yo 13 years)

Relative impact of influenza during match versus mismatched seasons

Timeframe: From 1996 to 2008 (up to 13 years)

Relative impact of influenza on vaccinated versus unvaccinated populations

Timeframe: From 1996 to 2008 (up to 13 years)

Secondary outcomes:
Not applicable
Interventions:
Other: Data collection
Enrollment:
1
Observational study model:
Other
Primary completion date:
Not applicable
Time perspective:
Retrospective
Clinical publications:
Bekkat-Berkani R et al. (2016) Evidence update: GlaxoSmithKline’s inactivated quadrivalent influenza vaccines. Expert Rev Vaccines. 15(2):201-214.
Fleming DM et al. (2016) Influenza-attributable burden in United Kingdom primary care. Epidemiol Infect. 144(3):537-547.
Medical condition
Influenza
Product
GSK2647158A
Collaborators
Sage Analytica
Study date(s)
September 2011 to October 2012
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female & Male
Age
Not applicable+ years
Accepts healthy volunteers
No
  • Registration with an acceptable flag in the GPRD, or registration with a potentially influenza-related event in the HES database or the ONS mortality data.

Trial location(s)

No location data available.

Study documents

Scientific result summary
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Refer to study documents

Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2012-03-10

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website